| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041657 Topical semi-crystalline beta-1,4-n-acetylglucosamine polymers free of proteins and contaminants; stimulating endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/04/2006 | WO2006046626A1 Water-soluble elastins, process for producing the same, and food and medicine containing the same |
| 05/04/2006 | WO2006045459A1 Thrombin inhibitors |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | US20060094667 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 05/04/2006 | US20060094650 Agent for improving life expectancy in therapy of malignant tumor |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060094079 Protein for blocking platelet adhesion |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652536A1 Wound treatment agent comprising a zeolite iod clathrat |
| 05/03/2006 | EP1651677A2 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 05/03/2006 | EP1651245A1 A composition for decreasing the risk of long-haul traveller's syndrome comprising a mixture of pycnogenol and standardized ginger root extract |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/03/2006 | EP1450788B8 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | EP1107813B1 Kit for creating in situ, chemically cross-linked, mechanical barriers or covering structures for vascular puncture sites |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP1037923B9 Method for preparing by filtration a virally secure factor viii solution |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768138A Method for producing recombinant proteins in micro-organisms |
| 05/03/2006 | CN1768071A Lipid-regulating agent and use thereof |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1766100A Agkistrodonacutus thrombin preparation method and uses |
| 05/03/2006 | CN1765920A Gen-seng protein separation method and uses of the gen-seng protein |
| 05/03/2006 | CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1765392A Chinese compound formulation for nourishing blood, regulating menstruation, stopping bleeding to prevent abortion and preparation method thereof |
| 05/03/2006 | CN1765389A Gall relieving pill |
| 05/03/2006 | CN1254473C Process for crystallization of(R)-or(S)-lansoprazole |
| 05/03/2006 | CN1254275C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 05/03/2006 | CN1254274C Recombinant hirudin oral enteric soluble slowly-releasing preparation |
| 05/03/2006 | CN1254273C Pharmaceutically stable hemostatic compositions |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/02/2006 | US7038074 Arginine mimetics as factor Xa inhibitors |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038020 Diagnosis of RH factor; using polypeptides to form antibodies |
| 05/02/2006 | US7038016 Dissolving a stable, activated polyoxyethylene glycol (carboxymethyloxy-end group)(aPEG) in a solvent; filtering the the solution to reduce the bioburden/endotoxin levels; used for the preparation of a PEGylated hemoglobin solution |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037911 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 04/27/2006 | WO2006044582A2 Use of baff to treat sepsis |
| 04/27/2006 | WO2006043594A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | WO2006042481A1 Method of obtaining clopidogrel |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088606 Methods and compositions for use in perfusion applications |
| 04/27/2006 | US20060088573 Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088531 Human antibodies against human glycoprotein VI and their use |
| 04/27/2006 | US20060088518 Stable thrombin composition |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | US20060088502 Drug for reducing side effects in ribavirin interferon combination therapy |
| 04/27/2006 | CA2583900A1 Use of baff to treat sepsis |
| 04/27/2006 | CA2583153A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | CA2574518A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1649867A1 Stable thrombin composition |
| 04/26/2006 | EP1648924A2 Dipeptide transglutaminase inhibitors and methods of using the same |
| 04/26/2006 | EP1648903A2 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 04/26/2006 | EP1648232A2 Method of treating hit patients with argatroban |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1294689B1 Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt |
| 04/26/2006 | EP1185666B1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 04/26/2006 | EP1056779B1 Method for producing a factor viii/von willebrand factor complex |
| 04/26/2006 | EP0966536B1 Factor x analogues with a modified protease cleavage site |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764462A T-type calcium channel blockers |
| 04/26/2006 | CN1764372A Autologous or homologous coagulant produced from anticoagulated whole blood |
| 04/26/2006 | CN1762424A Sutellaria root pills formula and its preparation method |